Literature DB >> 10708429

Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures.

A Mangé1, N Nishida, O Milhavet, H E McMahon, D Casanova, S Lehmann.   

Abstract

Transmissible spongiform encephalopathies form a group of fatal neurodegenerative disorders that have the unique property of being infectious, sporadic, or genetic in origin. Although some doubts about the nature of the responsible agent of these diseases remain, it is clear that a protein called PrP(Sc) plays a central role. PrP(Sc) is a conformational variant of PrP(C), the normal host protein. Polyene antibiotics such as amphotericin B have been shown to delay the accumulation of PrP(Sc) and to increase the incubation time of the disease after experimental transmission in laboratory animals. Unlike for Congo red and sulfated polyanions, no effect of amphotericin B has been observed in infected cultures. We show here for the first time that amphotericin B can inhibit PrP(Sc) generation in scrapie-infected GT1-7 and N2a cells. Its activity seems to be related to a modification of the properties of detergent-resistant microdomains. These results provide new insights into the mechanism of action of amphotericin B and confirm the usefulness of infected cultures in the therapeutic research of transmissible spongiform encephalopathies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708429      PMCID: PMC111813          DOI: 10.1128/jvi.74.7.3135-3140.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Complementary hydropathy identifies a cellular prion protein receptor.

Authors:  V R Martins; E Graner; J Garcia-Abreu; S J de Souza; A F Mercadante; S S Veiga; S M Zanata; V M Neto; R R Brentani
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

2.  BSE and prions: uncertainties about the agent.

Authors:  B Chesebro
Journal:  Science       Date:  1998-01-02       Impact factor: 47.728

Review 3.  Prion protein biology.

Authors:  S B Prusiner; M R Scott; S J DeArmond; F E Cohen
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

4.  Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains.

Authors:  M Vey; S Pilkuhn; H Wille; R Nixon; S J DeArmond; E J Smart; R G Anderson; A Taraboulos; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  The anti-prion activity of Congo red. Putative mechanism.

Authors:  S Caspi; M Halimi; A Yanai; S B Sasson; A Taraboulos; R Gabizon
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

6.  Effectiveness of polyene antibiotics in treatment of transmissible spongiform encephalopathy in transgenic mice expressing Syrian hamster PrP only in neurons.

Authors:  R Demaimay; R Race; B Chesebro
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  GPI-anchored proteins are organized in submicron domains at the cell surface.

Authors:  R Varma; S Mayor
Journal:  Nature       Date:  1998-08-20       Impact factor: 49.962

8.  Microdomains of GPI-anchored proteins in living cells revealed by crosslinking.

Authors:  T Friedrichson; T V Kurzchalia
Journal:  Nature       Date:  1998-08-20       Impact factor: 49.962

9.  Cholesterol-dependent retention of GPI-anchored proteins in endosomes.

Authors:  S Mayor; S Sabharanjak; F R Maxfield
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

10.  Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains.

Authors:  T M Stulnig; M Berger; T Sigmund; D Raederstorff; H Stockinger; W Waldhäusl
Journal:  J Cell Biol       Date:  1998-11-02       Impact factor: 10.539

View more
  35 in total

1.  Prion infection impairs the cellular response to oxidative stress.

Authors:  O Milhavet; H E McMahon; W Rachidi; N Nishida; S Katamine; A Mangé; M Arlotto; D Casanova; J Riondel; A Favier; S Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Development of in vitro cell cultures for the evaluation of molecules with antiprionic activity.

Authors:  C Pollera; G Carcassola; W Ponti; G Poli
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

3.  Development of in vitro cell cultures for the evaluation of molecules with antiprionic activity.

Authors:  C Pollera; G Carcassola; W Ponti; G Poli
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

4.  Mefloquine, an antimalaria drug with antiprion activity in vitro, lacks activity in vivo.

Authors:  David A Kocisko; Byron Caughey
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Variety of antiprion compounds discovered through an in silico screen based on cellular-form prion protein structure: Correlation between antiprion activity and binding affinity.

Authors:  Junji Hosokawa-Muto; Yuji O Kamatari; Hironori K Nakamura; Kazuo Kuwata
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

6.  New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.

Authors:  David A Kocisko; Gerald S Baron; Richard Rubenstein; Jiancao Chen; Salomon Kuizon; Byron Caughey
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Progress and problems in the biology, diagnostics, and therapeutics of prion diseases.

Authors:  Adriano Aguzzi; Mathias Heikenwalder; Gino Miele
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Dennisse Gonzalez-Romero; Kristi Green; Giulio Taglialatela; Claudio Soto
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

Review 9.  Optimizing efficacy of Amphotericin B through nanomodification.

Authors:  Gillian Barratt; Stéphane Bretagne
Journal:  Int J Nanomedicine       Date:  2007

10.  Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation.

Authors:  Sabine Gilch; Christian Bach; Gloria Lutzny; Ina Vorberg; Hermann M Schätzl
Journal:  Cell Mol Life Sci       Date:  2009-10-13       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.